v3.25.2
Stockholders’ Equity
 6 Months Ended
Jun. 30, 2025
Stockholders’ Equity [Abstract]  
Stockholders’ Equity
(4) Stockholders’ Equity
 
Stock-Based Compensation
 
The Company applies ASC 718, Compensation–Stock Compensation (Topic 718) (“ASC 718”), to account for stock-based compensation.
 
The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and six months ended June 30:
 
                
   3 Months Ended     6 Months Ended  
   June 30,     June 30,  
   
2025
    
2024
    
2025
    
2024
 
                    
Data and product costs
$9,541   $7,956   $18,000   $15,551 
Selling, general and administrative expenses
 13,642    14,664    32,468    32,062 
                    
  $23,183   $22,620   $50,468   $47,613 
 
Stock Options
 
On April 1, 2025, the Company issued 45,100 shares of common stock upon the exercise of stock options. The stock options had a weighted-average exercise price of $2.15 per share. The Company received cash proceeds totaling $96,935 in connection with the exercise of these stock options. The total intrinsic value of the stock options exercised during the three and six months ended June 30, 2025 was approximately $20,325.
 
There were no stock options exercised during the three and six months ended June 30, 2024.